Cargando…
ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is labeled with high mortality and tolerance to chemotherapy. Sorafenib has been the first‐line treatment option in HCC patients for past decades, while the therapeutic effect was limited in almost HCC patients. METHODS: In this study, we analyzed public om...
Autores principales: | Shi, Ying, Shang, Jin, Li, Yan, Zhong, Deyuan, Zhang, Zilong, Yang, Qinyan, Lai, Chunyou, Feng, Tianhang, Yao, Yutong, Huang, Xiaolun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939139/ https://www.ncbi.nlm.nih.gov/pubmed/35946175 http://dx.doi.org/10.1002/cam4.5110 |
Ejemplares similares
-
Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma
por: Zhang, Zilong, et al.
Publicado: (2022) -
Prognostic value of inflammation‐immunity‐nutrition score in patients with hepatocellular carcinoma treated with anti‐PD‐1 therapy
por: Zhang, Zilong, et al.
Publicado: (2022) -
Gynura segetum-induced liver injury leading to acute liver failure: a case report and literature review
por: Zhang, Zilong, et al.
Publicado: (2022) -
ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis
por: Feng, Tianhang, et al.
Publicado: (2023) -
The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)